Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07737938Not ApplicableNot Yet Recruiting

Lactic Acid Bacteria for Reducing Blue Light-Induced Eye Fatigue

Role: lead

NCT06724185Not ApplicableCompleted

Effects of LP28 on Immunity Enhancement in the Elderly

Role: lead

NCT04293666Not ApplicableCompleted

Functional Evaluation of Kefir Drink on Antifatigue and Exercise Exercise Performance-2

Role: collaborator

NCT05412667Not ApplicableCompleted

Investigation of TWK10 Administration on the Effects of Amino Acid Absorption

Role: collaborator

NCT04893746Not ApplicableCompleted

TWK10 Improves Muscle Mass and Functional Performance in Frail Older Adults

Role: collaborator

All 5 trials loaded